Share through
St. Jude Research Logo
About Us
Care & Treatment
Research
Training
Get Involved
Ways to Give
St. Jude Research
WHY ST. JUDE
Back
WHY ST. JUDE
Data and Visualization Tools
Shared Resources
Why St.Jude
Translation Innovation
Scientific Milestones
DEPARTMENTS & LABS
Back
DEPARTMENTS & LABS
Departments
View all departments
Labs
View all labs
Clinical Research
View all clinical researchers
CENTERS & INITIATIVES
Back
CENTERS & INITIATIVES
Comprehensive Cancer Center
Pediatric Translational Neuroscience Initiative
Blue Sky
St. Jude Research Collaboratives
Centers & Initiatives
Global Impact on Infectious Disease
Center of Excellence for Data-Driven Discovery
Center of Excellence for Innate Immunity and Inflammation
Center of Excellence for Pediatric Immuno-Oncology
CAREERS
Home
Why St. Jude
Shared resources & core facilities
Technology Licensing
Drug discovery & development tools
Drug discovery & development tools
ARF and HDM2 interaction domains (SJ-01-0016)
Alternate mTOR Pathway (SJ-09-0021)
Assay for ATM Kinase Modulation (SJ-02-0008)
BMP Compounds for treating diseases caused by defective or diminished BMP signaling (Medulloblastoma) - (SJ-15-0008)
Caspase 1 inhibition (SJ-13-0039)
Cells That Lack p19Ink4d and p27Kip1 Activity/p19Ink4d and p27Kip1 Null Mice (SJ-98-0023)
Chimeric gene and protein generated Optogranules: Light induced stress granules (SJ-18-0010)
DCN1 Inhibitors (SJ-16-0002)
Defects in LC3-associated phagocytosis (LAP) associated with lupus (SJ-16-0025)
Diagnosing and treating learning or mental disorders with SERCA2 protein and miRNAs (SJ-10-0003, SJ-12-0020)
Discovery of a fluorescent vinblastine analog with high affinity to the human pregnane X receptor (hPXR) Ligand (SJ-13-0009)
Discovery of a novel inhibitor of constitutive androstane receptor (CAR) that does not activate pregnane X receptor (PXR) (SJ-14-0039)
FRET assay for G3BP1 and G3BP2 inhibitors (SJ-19-0043)
Hematopoietic progenitor cell lines with myeloid and lymphoid potential (SJ-11-0003)
Identification of Toll-like receptor signaling inhibitors (SJ-18-0008)
Inhibiting Mir-451 to treat Beta-Thalassemia (SJ-20-0030)
Interaction of Reelin With Very Low Density Lipoprotein (VLDL) Receptor (SJ-98-0045)
LANDO pathway disruption for Alzheimer's disease (SJ-19-0020)
Method for Enhancing Recombinant Antibody Production (SJ-08-0032)
Modulating non-canonical autophagy (LAP) in myeloid cells to suppress tumors (SJ-17-0019)
NLRP12 Activators and Screening Tool (SJ-23-0016)
Ozz, A Protein That Regulates Development and Function of Muscle Cells (SJ-99-0010)
Preventing and treating hearing loss using CDK2 inhibitors (SJ-14-0028)
Rapid cloning of T cell receptors (SJ-16-0001)
Regulating p53 translation and function (SJ-05-0002)
Respiratory cell isolation and propagation for pathogen study (SJ-18-0028)
SCCRO peptide inhibitor (SJ-11-0014)
Small molecule BODIPY FL VH032 probe for E3 ligase (SJ-21-0014)
Specific retinoid receptor agonists and antagonists for cancer (SJ-14-0011)
miRNAs for treating cerebral ventricle enlargement in schizophrenia patients (SJ-19-0039)
For more information
Contact the
Office of Technology Licensing
:
Phone: (901) 595-2342
Fax: (901) 595-3148
OTL Intellectual Properties Newsletters
More technologies
Antibodies for basic research
Biologics
Diagnostics
Drugs
Other technologies
Vaccines
Contact Us
View all Shared Resources